The board of directors (the "Board") of Tianjin TEDA Biomedical Engineering Company Limited (the "Company") announces that the address of the principal place of business of the Company in Hong Kong will be changed to Room 3105, 31/F. Tower 1 Lippo Centre, No. 89 Queensway, Admiralty effect from 14 June 2023.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 HKD | 0.00% | +8.70% | -15.73% |
1st Jan change | Capi. | |
---|---|---|
-15.73% | 18.18M | |
-16.21% | 14.47B | |
-6.35% | 13.87B | |
+4.01% | 12.3B | |
-18.22% | 9.13B | |
-.--% | 7.32B | |
-12.29% | 7.22B | |
-4.38% | 6.4B | |
-3.48% | 4.26B | |
-32.16% | 2.26B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin TEDA Biomedical Engineering Company Limited Announces Change of Principal Place of Business in Hong Kong